While we did not find cut-off values that identified a class of subjects or patients among female and male with BPH, we found that PDE5 levels were significantly higher in PCa patients than in the No-PCa group, with a cut-off value of 12.705 ng/ml. This evidence concerns the gene PDE5A and benign prostatic hyperplasia.